---
$id: https://graph.org.ai/products/commodity/51372011
$type: Product
source: UNSPSC
code: "51372011"
title: "Levophenacylmorphan"
class: "51372000"
classTitle: "Controlled substance analgesic morphinans"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levophenacylmorphan

**UNSPSC Code**: 51372011
**Class**: [Controlled substance analgesic morphinans](Controlled substance analgesic morphinans.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C24H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Q24AL2BR2, chemically known as morphinan-3-ol, 17-(2-oxo-2-phenylethyl)- but generally known as levophenacylmorphan, which bears US NIH Compound Identifier 517743. European Medicines Agency schedules Levophenacylmorphan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08484MIG. The term LEVOPHENACYLMORPHAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). LEVOPHENACYLMORPHAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levophenacylmorphan under HS 29334990 and SITC 51575. As of Q4 2014, LEVOPHENACYLMORPHAN remains the US FDA Preferred Term for this commodity. Levophenacylmorphan bears US NLM identifiers UMLS ID C2827237 and NCI Concept Code C83880. SMILES: OC1CC2C34C(C(N(CC3)CC(=O)C3CCCCC3)CC2CC1)CCCC4.

